20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T28368 | PF-04859989 HCl | PF 04859989,PF04859989,PF-04859989HCl,PF-04859989 | Others |
PF-04859989 HCl is a brain-penetrable irreversible inhibitor of kynurenine amino transferase II (KAT II), the enzyme responsible for most of the brain synthesis of kynurenic acid. PF-04859989 HCl has been implicated in s... | |||
T24656 | PQ-10 | A844337,PQ 10,A-844337,A 844337 | PDE |
PQ-10 (A-844337) is a PDE-10 inhibitor. PQ-10 induces brain glucose metabolism patterns, which may be a potential translational biomarker. | |||
T7165 | Basmisanil | RG1662,RO5186582 | GABA Receptor |
Basmisanil (RG1662) is a negative allosteric modulator/inverse agonist of GABAAα5 receptors.Formulations containing basmisanil are in clinical trials for the treatment of cognitive impairments associated with Down syndro... | |||
T20324 | Butyrophenone | NSC8463,NSC 8463,NSC-8463 | Others |
Butyrophenone (NSC-8463) is a chemical compound. Some of its derivatives are used to treat various psychiatric disorders. | |||
T31079 | CP-810123 | CP 810123,UNII-E6G4550EC4,CP810123 | AChR |
CP-810123 is a new alpha 7 nAChR agonist for the treatment of cognitive impairment associated with psychiatric or neurological disorders such as schizophrenia and Alzheimer's disease. | |||
T50061 | [4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine | Others | |
[4-(4-phenylpiperazin-1-yl)oxan-4-yl]methanamine is a piperazine derivative that is a partial agonist at serotonin and dopamine receptors, making it a candidate for the treatment of psychiatric disorders such as depressi... | |||
T50054 | Opromazine hydrochloride | Others | |
Opromazine hydrochloride belongs to the phenothiazine class of antipsychotics and reduces the activity of dopaminergic pathways by blocking dopamine receptors in the brain. It is mainly used for the treatment of psychiat... | |||
T23066 | NGD 94-1 | Dopamine Receptor | |
NGD 94-1 is a selective D4 receptor antagonist with an affinity of 3 nM for the D4 receptor and greater than 2 pM for the D1, D2, D3, and D5 receptors.NGD 94-1 can be used in the study of cognitive disorders and other ps... | |||
T83974 | OPC18750 HCl | PDE | |
OPC18750 HCl is a potential phosphodiesterase inhibitor with positive inotropic effects that can be used to study asthma, cancer, diabetes, and psychiatric disorders. | |||
T77597 | SXC 2023 | (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid | Others |
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dys... | |||
T0024 | Primidone | Primaclone,Mysoline,NCI-C56360 | GABA Receptor , Sodium Channel , GluR , AChR |
Primidone (NCI-C56360) is a potent anticonvulsant agent. It is a neuronal voltage-gated sodium channel blocker and has value in the study of epilepsy, essential tremor, and psychiatric disorders. | |||
T1292 | Tiapride hydrochloride | Dopamine Receptor | |
Tiapride is a selective blocker of D2/3 dopamine receptors in the brain. It is used in the therapy of various psychiatric and neurological disorders containing dyskinesia, negative symptoms of psychosis, alcohol withdraw... | |||
T50111 | 6-Fluorotryptamine hydrochloride | Others | |
6-Fluorotryptamine hydrochloride is a compound used as a molecular structural unit and is a derivative of the natural tryptamine alkaloid serotonin. It is an agonist at 5-HT2A and 5-HT2C serotonin receptors, making it a ... | |||
T67811 | Tefludazine | ||
Tefludazine, a novel neuroleptic with a benzindone structure, is a compound with good oral activity and antagonistic effects on dopamine and 5-hydroxytryptamine receptors. Tefludazine has shown potent dopamine (DA) antag... | |||
T0256 | Citric acid trilithium salt tetrahydrate | Lithium citrate tribasic tetrahydrate,Trilithium citrate tetrahydrate | Dehydrogenase , GSK-3 , HIF/HIF Prolyl-Hydroxylase , Antibacterial , GluR |
Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) , the active component of Lithium, is a medicine used in the therapy of psychiatric disease. It has shown the effects of signaling pathways... | |||
T24766 | SBI-0061869 | SBI0061869 | |
SBI-0061869 is a potentiator of metabotropic glutamate receptors. It was used against neurological and psychiatric disorders. | |||
T39218 | (S)-CVN424 | (S)-CVN424 | |
(S)-CVN424 is a powerful modulator of G-Protein-Coupled Receptor 6 (GPR6), known for its involvement in neurological and psychiatric disorders research, such as Parkinson's disease. | |||
T28085 | Moperone Hydrochloride | EN1733A,EN 1733A,EN-1733A | |
Moperone Hydrochloride, a dopamine D2-receptor antagonist, is used for the treatment of psychiatric disorders. | |||
T24767 | SBI-0069332 | ||
SBI-0069332 is a potentiator of metabotropic glutamate receptors. It was used against neurological and psychiatric disorders. | |||
T39940 | Plazinemdor | ||
Plazinemdor is an NMDA receptor positive allosteric modulator with potential applications in psychiatric, neurological, neurodevelopmental disorders, and diseases of the nervous system. |